Hempire Labs expanded its pharmaceutical lab design and EU GMP compliance consulting services, supporting organizations developing pharmaceutical-grade production facilities for the regulated medical cannabis industry.
-- Spain-based Hempire Labs has announced an expansion of its consulting services to support pharmaceutical lab design and EU GMP compliance for organizations developing medical cannabis production facilities. The firm guides clients through laboratory planning, cleanroom engineering, process design, and regulatory alignment, helping businesses succeed in highly regulated environments.
More details can be found at https://hempirelabs.com
Europe’s expanding medical cannabis sector is driving demand for pharmaceutical-grade production infrastructure. The European Union Drugs Agency (EUDA) notes that more countries are introducing or broadening regulated access, underscoring the need for facilities that meet strict EU pharmaceutical quality standards. As a result, compliant laboratory design and alignment with EU GMP have become essential for both new and expanding operators.
Hempire Labs says its expanded consulting services help organizations proactively meet evolving regulatory and technical requirements before construction begins. The company provides support for laboratory layout, cleanroom engineering, environmental controls, and process workflows that align with GMP, Good Agricultural and Collection Practice (GACP), and Good Distribution Practice (GDP) standards across cultivation, extraction, and processing operations.
The consultancy's approach combines established pharmaceutical design principles with the specialized requirements of regulated medical cannabis production. Facility planning may include contamination-control zoning strategies, controlled HVAC systems, and cleanroom environments designed around classifications such as ISO 5 and ISO 7 to help maintain product quality and inspection readiness. According to the company, integrating compliance at the design stage helps minimize costly modifications later in a project’s lifecycle.
“Building a compliant facility means aligning engineering decisions with regulatory standards from the start,” said a Hempire Labs spokesperson. “Integrating GMP into the design reduces redesign costs, improves efficiency, and prepares organizations for evolving industry compliance.”
Hempire Labs supports projects from initial concept to commissioning, coordinating technical planning, documentation, and quality management systems needed for regulatory approval. The firm's consulting services help operators establish cultivation, extraction, and processing facilities that meet international manufacturing and quality standards.
About Hempire Labs
Hempire Labs is a medical cannabis laboratory design and compliance consultancy founded in 2019 and based in Sotogrande, Spain. Founded by medical cannabis entrepreneur Mardi Joubanian and project manager Paulina Molyneux-Webb, the firm advises organizations worldwide on GMP-, GACP-, and GDP-aligned facility planning for cultivation, extraction, and processing operations.
More information is available at https://hempirelabs.com
Contact Info:
Name: Paulina Molyneux-Webb
Email: Send Email
Organization: Hempire Labs S.L.
Address: C.C., Mar y Sol Local 3.9, Sotogrande, Andalucía 11310, Spain
Website: https://hempirelabs.com
Source: NewsNetwork
Release ID: 89199992
In case of detection of errors, concerns, or irregularities in the content provided in this press release, or if there is a need for a press release takedown, we strongly encourage you to reach out promptly by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for immediate assistance within 8 hours – resolving identified issues diligently or guiding you through the removal process. We take great pride in delivering reliable and precise information to our valued readers.
